Cureline, Inc., is a global translational and biomarker CRO, focused on providing biospecimens procurement, management, and analysis services in the following areas: molecular diagnostics, biomarkers, drug R&D, preventive and predictive medicine, translational research, and personalized medicine. Since 2003, we have collaborated with leading clinical and research centers in the USA, Europe, and Asia on human tissue acquisition, processing and distribution.
We have expertise in a wide range of therapeutic fields, including Oncology, Inflammation, Cardiovascular diseases, Diabetes/Obesity, Infectious diseases (including in-hospital infections), CNS disorders, Inherited conditions, and others.
Cureline provides high-quality, well characterized human biospecimens and tissue-related services to biomedical research community allowing accelerated identification and validation of drug targets, development of companion diagnostic tests, discovery and development of biomarker assays and, overall, facilitating the personalized approach in medicine.
Our offices are located in South San Francisco (California, USA), St. Petersburg (Russia) and in Central/South-Pacific Asia. 25 employees with advanced degrees in life sciences, medicine and business development ensure implementation of the complex projects.